89 related articles for article (PubMed ID: 2779163)
21. Renal prostaglandin E2 and F2 alpha synthesis during exercise: effects of indomethacin and sulindac.
Zambraski EJ; Dodelson R; Guidotti SM; Harnett CA
Med Sci Sports Exerc; 1986 Dec; 18(6):678-84. PubMed ID: 3537627
[TBL] [Abstract][Full Text] [Related]
22. Effect of furosemide on renal prostaglandins E2 and F2 alpha in normal subjects and in patients with essential hypertension.
Rathaus M; Bauminger S; Bernheim J
Isr J Med Sci; 1980 Feb; 16(2):106-10. PubMed ID: 7364563
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical localization of prostaglandins E and F2 alpha in the developing murine palate.
Jones J; Shanfeld J; Davidovitch Z; Greene RM
J Craniofac Genet Dev Biol; 1986; 6(1):63-71. PubMed ID: 3517033
[TBL] [Abstract][Full Text] [Related]
24. Effect of atenolol treatment on urinary prostaglandins E2 and F2 alpha in essential hypertension.
Rathaus M; Magen A; Rath-Wolfson L; Shapira J; Bernheim J
Isr J Med Sci; 1983 Dec; 19(12):1072-4. PubMed ID: 6582055
[TBL] [Abstract][Full Text] [Related]
25. Validation of radioimmunoassays to measure prostaglandins F2 alpha and E2 in canine endometrium and plasma.
Olson PN; Bowen RA; Behrendt MD; Olson JD; Nett TM
Am J Vet Res; 1984 Jan; 45(1):119-24. PubMed ID: 6584054
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
Yousufzai SY; Ye Z; Abdel-Latif AA
Exp Eye Res; 1996 Sep; 63(3):305-10. PubMed ID: 8943703
[TBL] [Abstract][Full Text] [Related]
27. [Prostaglandins in the pathogenesis of vascular lesions in patients with rheumatic diseases].
Pribytkov IuN; Shilkina NP; Poltyrev AS
Revmatologiia (Mosk); 1990; (3):7-11. PubMed ID: 1983044
[TBL] [Abstract][Full Text] [Related]
28. [Effect of acute furosemide load on the level of blood prostaglandins in healthy persons and patients with hypertension].
Shkhvatsabaia IK; Gazarian GA; Nekrasova AA
Ter Arkh; 1978; 50(12):41-6. PubMed ID: 741372
[No Abstract] [Full Text] [Related]
29. Improved quantification of 8-epi-prostaglandin F2 alpha and F2-isoprostanes by gas chromatography/triple-stage quadrupole mass spectrometry: partial cyclooxygenase-dependent formation of 8-epi-prostaglandin F2 alpha in humans.
Schweer H; Watzer B; Seyberth HW; Nüsing RM
J Mass Spectrom; 1997 Dec; 32(12):1362-70. PubMed ID: 9423285
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandins and glutathione peroxidase in bovine mastitis.
Atroshi F; Parantainen J; Sankari S; Osterman T
Res Vet Sci; 1986 May; 40(3):361-6. PubMed ID: 3461513
[TBL] [Abstract][Full Text] [Related]
31. Dissociation of effects of xanthine analogs on renal prostaglandins and renal excretory function in the awake rat.
Baer PG; Armstrong EL; Cagen LM
J Pharmacol Exp Ther; 1983 Dec; 227(3):600-4. PubMed ID: 6581288
[TBL] [Abstract][Full Text] [Related]
32. [Determination of primary prostaglandin (Pgs) and main metabolite of PgF2 alpha in blood plasma for diagnosis of primary dysmenorrhoea].
Seifert B; Liedtke MP
Zentralbl Gynakol; 1982; 104(10):577-83. PubMed ID: 6957086
[TBL] [Abstract][Full Text] [Related]
33. [Functional changes in the liver in Itsenko-Cushing syndrome].
Zlatkina AR; Kamynina TS
Klin Med (Mosk); 1975 Aug; 53(8):23-7. PubMed ID: 1186083
[No Abstract] [Full Text] [Related]
34. [Changes in prostaglandin levels in the blood of patients with various forms of chronic colitis before and after treatment].
Shafer NP; Askarov UA
Klin Med (Mosk); 1990 Dec; 68(12):56-8. PubMed ID: 1982155
[TBL] [Abstract][Full Text] [Related]
35. [Natural anti-PGF2alpha and anti-PGE2 antibodies in ischemic heart disease and hypertension].
Korochkin IM; Verbitskaia IA; Okuneva IN; Krupnik VE; Polevaia OIu
Sov Med; 1991; (1):25-7. PubMed ID: 1862375
[TBL] [Abstract][Full Text] [Related]
36. [Veloergometric test in the evaluation of work capacity in patients with Itsenko-Cushing syndrome].
Vasiukova EA; Korchagina VG; Granovskaia-Tsvetkova AM; Ametov AS
Sov Med; 1979 Oct; (10):99-103. PubMed ID: 524181
[No Abstract] [Full Text] [Related]
37. [The importance of immunogenetic studies in Itsenko-Cushing disease combined with other endocrine diseases].
Kalinin AP; Andrusenko AB; Zaretskaia IuM; Abramov VIu; Klinova EG; Bogatyrev OP; Donskov SI; Manishkina RP
Ter Arkh; 1992; 64(2):103-8. PubMed ID: 1509359
[TBL] [Abstract][Full Text] [Related]
38. [Urine excretion of PGE2, PGF2 alpha in patients with deficiency-cold syndrome and deficiency-heat syndrome].
Guo YG; Xie ZF
Zhong Xi Yi Jie He Za Zhi; 1990 Oct; 10(10):593-5, 580. PubMed ID: 2268916
[TBL] [Abstract][Full Text] [Related]
39. [Adenohypophysis function in Itsenko-Cushing disease before and after proton-beam irradiation].
Bel'chenko LV; Kirpatovskaia LE; Marova EI; Kolesnikova GS; Dobracheva AD
Zh Vopr Neirokhir Im N N Burdenko; 1989; (5):31-2. PubMed ID: 2556878
[No Abstract] [Full Text] [Related]
40. [Role of the kidneys in pathogenesis of hypertension in Itsenko-Cushing disease].
Mkrtumian AM; Gerasimova NP
Ter Arkh; 1979; 51(3):71-6. PubMed ID: 441959
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
